1-2 of 2
Shripad Bhagwat, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AC220, a Potent and Specific FLT3 Inhibitor, Enhances the Cytotoxic Effects of Chemotherapeutic Agents in Cell Culture and in Mouse Tumor Xenografts.

Barbara A. Belli, Ph.D., Alan Dao, B.S., Shripad Bhagwat, Ph.D., Wendell Wierenga, PhD, Robert C Armstrong, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2052.
https://doi.org/10.1182/blood.V114.22.2052.2052
Published: 2009
Journal Articles

AC220, a FLT3 Inhibitor, Increases Survival in Two Genotypically Distinct FLT3-ITD Models of Acute Myeloid Leukemia and Provides Sustained Protection Following Chronic Administration.

Daniel Brigham, B.S., Barbara A. Belli, Ph.D., Michael Breider, Ph.D, DVM, Shripad Bhagwat, Ph.D., Wendell Wierenga, PhD, Robert C Armstrong, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2053.
https://doi.org/10.1182/blood.V114.22.2053.2053
Published: 2009